Since in our data miR-7-2-3p is overexpressed in ALS patients, we can suggest that a downregulation of Cyclin D1 and consequent deactivation of Wnt/β-catenin pathway might increase the disease progression. This evidence concerns the gene CCND1 and amyotrophic lateral sclerosis.